Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Apr 2013

Huang Chung-Feng, Yu Ming-Lung, Kao Jia-Horng, Tseng Tai-Chung, Yeh Ming-Lun, Huang Jee-Fu, Dai Chia-Yen, Lin Zu-Yau, Chen Shinn-Cherng, Wang Liang-Yen, Juo Suh-Hang Hank, Chuang Wan-Long, Liu Chen-Hua

Abstract excerpt

BACKGROUND: Viral kinetics and host interleukin 28B (IL-28B) genotype determine treatment outcome in hepatitis C virus genotype 1 (HCV-1) infection. OBJECTIVES: We aimed to explore the interplay between interferon responsiveness at treatment week 4 and IL28B genotype in the achievement of a susta...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspartate Aminotransferases
Share to Hemoglobins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Interferons

Share to Interleukins

Share to Platelet Count

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 23246359
DOI: 10.1016/j.jcv.2012.11.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23246359-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype.PMID 23246359Read ↗

Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin.Semantic proximity Read ↗

Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1.Semantic proximity Read ↗

Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy.Semantic proximity Read ↗

The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.Semantic proximity Read ↗

Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1.Semantic proximity Read ↗

Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring.Semantic proximity Read ↗

Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3.Semantic proximity Read ↗

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.Semantic proximity Read ↗

Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.Semantic proximity Read ↗

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.Semantic proximity Read ↗

High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).Semantic proximity Read ↗

Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.